Entegris Inc (ENTG) surpasses guidance with robust Q1 financials and strategic advancements, setting a positive trajectory for 2024.
Despite mixed segment performance and macroeconomic pressures, TECH maintains a robust strategic outlook with key advancements in diagnostics and genomics.
Insight into SMG's Q2 performance, featuring significant debt reduction, improved cash flow, and ongoing challenges in the Hawthorne segment.